302 related articles for article (PubMed ID: 29224373)
1. Pharmacotherapy and treatment options for HIV-associated nephropathy.
Menez S; Hanouneh M; McMahon BA; Fine DM; Atta MG
Expert Opin Pharmacother; 2018 Jan; 19(1):39-48. PubMed ID: 29224373
[TBL] [Abstract][Full Text] [Related]
2. Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy.
Foy MC; Estrella MM; Lucas GM; Tahir F; Fine DM; Moore RD; Atta MG
Clin J Am Soc Nephrol; 2013 Sep; 8(9):1524-32. PubMed ID: 23685946
[TBL] [Abstract][Full Text] [Related]
3. HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study.
Abbott KC; Trespalacios FC; Agodoa LY; Ahuja TS
BMC Nephrol; 2003 Jul; 4():5. PubMed ID: 12837135
[TBL] [Abstract][Full Text] [Related]
4. Predictors of HIV-associated nephropathy.
Waheed S; Atta MG
Expert Rev Anti Infect Ther; 2014 May; 12(5):555-63. PubMed ID: 24655211
[TBL] [Abstract][Full Text] [Related]
5. HIV-associated nephropathy: case study and review of the literature.
Ross MJ; Klotman PE; Winston JA
AIDS Patient Care STDS; 2000 Dec; 14(12):637-45. PubMed ID: 11119430
[TBL] [Abstract][Full Text] [Related]
6. Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy.
Razzak Chaudhary S; Workeneh BT; Montez-Rath ME; Zolopa AR; Klotman PE; Winkelmayer WC
Nephrol Dial Transplant; 2015 Oct; 30(10):1734-40. PubMed ID: 26175146
[TBL] [Abstract][Full Text] [Related]
7. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
8. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection.
Szczech LA; Gupta SK; Habash R; Guasch A; Kalayjian R; Appel R; Fields TA; Svetkey LP; Flanagan KH; Klotman PE; Winston JA
Kidney Int; 2004 Sep; 66(3):1145-52. PubMed ID: 15327410
[TBL] [Abstract][Full Text] [Related]
9. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection.
Winston JA; Klotman ME; Klotman PE
Kidney Int; 1999 Mar; 55(3):1036-40. PubMed ID: 10027941
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and outcomes of HIV-associated immune complex kidney disease.
Booth JW; Hamzah L; Jose S; Horsfield C; O'Donnell P; McAdoo S; Kumar EA; Turner-Stokes T; Khatib N; Das P; Naftalin C; Mackie N; Kingdon E; Williams D; Hendry BM; Sabin C; Jones R; Levy J; Hilton R; Connolly J; Post FA;
Nephrol Dial Transplant; 2016 Dec; 31(12):2099-2107. PubMed ID: 26786550
[TBL] [Abstract][Full Text] [Related]
11. Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition.
Wei A; Burns GC; Williams BA; Mohammed NB; Visintainer P; Sivak SL
Kidney Int; 2003 Oct; 64(4):1462-71. PubMed ID: 12969167
[TBL] [Abstract][Full Text] [Related]
12. Captopril and renal survival in patients with human immunodeficiency virus nephropathy.
Kimmel PL; Mishkin GJ; Umana WO
Am J Kidney Dis; 1996 Aug; 28(2):202-8. PubMed ID: 8768914
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era.
Abbott KC; Hypolite I; Welch PG; Agodoa LY
J Nephrol; 2001; 14(5):377-83. PubMed ID: 11730270
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus-1 associated nephropathy (HIVAN): epidemiology, pathogenesis, histology, diagnosis, and medical management.
Lochner ML; Wolf A
Nephrol Nurs J; 2006; 33(3):259-67; quiz 268-9. PubMed ID: 16859198
[TBL] [Abstract][Full Text] [Related]
15. Is the prevalence of HIV-associated nephropathy decreasing?
Ahuja TS; Borucki M; Funtanilla M; Shahinian V; Hollander M; Rajaraman S
Am J Nephrol; 1999; 19(6):655-9. PubMed ID: 10592359
[TBL] [Abstract][Full Text] [Related]
16. [The methods of therapy ESRD patients infected with the human immunodeficiency virus-HIV].
Gozdowska J; Durlik M
Przegl Lek; 2008; 65(2):82-6. PubMed ID: 18663906
[TBL] [Abstract][Full Text] [Related]
17. The clinical characteristics and antiretroviral dosing patterns of HIV-infected patients receiving dialysis.
Szczech LA; Kalayjian R; Rodriguez R; Gupta S; Coladonato J; Winston J;
Kidney Int; 2003 Jun; 63(6):2295-301. PubMed ID: 12753321
[TBL] [Abstract][Full Text] [Related]
18. Presentation of HIV-associated nephropathy and outcome in HAART-treated patients.
Bigé N; Lanternier F; Viard JP; Kamgang P; Daugas E; Elie C; Jidar K; Walker-Combrouze F; Peraldi MN; Isnard-Bagnis C; Servais A; Lortholary O; Noël LH; Bollée G
Nephrol Dial Transplant; 2012 Mar; 27(3):1114-21. PubMed ID: 21745806
[TBL] [Abstract][Full Text] [Related]
19. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa.
Han TM; Naicker S; Ramdial PK; Assounga AG
Kidney Int; 2006 Jun; 69(12):2243-50. PubMed ID: 16672914
[TBL] [Abstract][Full Text] [Related]
20. HIV-associated nephropathy.
Khan S; Haragsim L; Laszik ZG
Adv Chronic Kidney Dis; 2006 Jul; 13(3):307-13. PubMed ID: 16815235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
